Evidence map›Paper›PMID 42622364›Full record

ArticleJournal of industrial microbiology & biotechnology2026

Evaluating the efficacy of disinfecting products against Bacillus subtilis spore using an optimized method.

Yoonsung Hu, Jinshan Jin, Haijing Hu, Ian F Deveau, Steven L Foley, Huizhong Chen

Abstract readEvaluation Study
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yoonsung HuDivision of Microbiology, National Center for Toxicological Research, U.S. FDA, Jefferson, AR 72079, United States.ORCID 0000-0002-5976-4318
Jinshan JinDivision of Microbiology, National Center for Toxicological Research, U.S. FDA, Jefferson, AR 72079, United States.
Haijing HuOffice of Compounding Quality and Compliance, Center for Drug Evaluation and Research, U.S. FDA, Silver Spring, MD 20993, United States.
Ian F DeveauOffice of Compounding Quality and Compliance, Center for Drug Evaluation and Research, U.S. FDA, Silver Spring, MD 20993, United States.
Steven L FoleyDivision of Microbiology, National Center for Toxicological Research, U.S. FDA, Jefferson, AR 72079, United States.ORCID 0000-0003-3146-4548
Huizhong ChenDivision of Microbiology, National Center for Toxicological Research, U.S. FDA, Jefferson, AR 72079, United States.ORCID 0000-0002-9160-6571

Funding

U.S. Department of EnergyU.S. Food and Drug Administration E0771701
6 · The paper itself

Abstract

Twenty disinfectant products were evaluated for sporicidal activity using an optimized method. Bacillus subtilis ATCC 6051 was sporulated in Difco sporulation medium for 3 days. The spores were purified using density centrifugation and heat treatment and then prepared for sporicidal efficacy assessment. The quality of the purified spores was verified using sodium hypochlorite solutions with free chlorine concentrations of 1,500 and 5,000 ppm. The active ingredients in disinfectant products included chlorine, hydrogen peroxide/peracetic acid, aldehydes, quaternary ammonium compounds, and phenols. Of the 20 products tested, 6 met the effectiveness criterion of greater than a 5 log₁₀ reduction after exposure of B. subtilis spores for the label-recommended contact time. Among the 11 products claiming sporicidal activity, 4 met the established criterion. Among the five categories of active ingredients evaluated, some chlorine-based and hydrogen peroxide/peracetic acid-based products demonstrated significantly higher sporicidal activity than products in the other three categories. Overall, products that did not meet the study criteria exhibited less than a 1 log₁₀ reduction. When these underperforming sporicidal products were tested with an extended contact time of 10 min, one additional product met the effectiveness criterion. Subsequent quality assessments using freshly prepared, laboratory-made products containing identical active ingredients demonstrated improved sporicidal efficacy compared with the original test items, indicating that defects or degradation of active ingredients may have occurred in some of the tested commercial disinfectant products. One sentence summary Evaluation of 20 disinfectants against Bacillus subtilis spores using optimized methods.

Indexed as

Bacillus subtilisDisinfectantsSpores, BacterialHydrogen PeroxideMicrobial ViabilitySodium HypochloriteDisinfectantsHydrogen PeroxideSodium Hypochloritebacillusdisinfectant neutralizationpharmaceutical compoundingsporesporicidal

Identifiers

PMID42622364
PMCPMC13548849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.